Received Aug 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
did not receive second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose in October 2022). The patient did not receive the 2nd dose of Shingrix. The patient had incomplete course of vaccination (Verbatim: did not receive second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 15-AUG-2025 The patient did not receive Hz/su + AS01B was Shingrix. The reporter reported that the patient received the first dose in October 2022 and did not receive the second dose yet. Till the time of reporting, the patients did not receive the second dose of Shingrix, which led to incomplete course of vaccination.